Global "hold-em".
作者信息
Cassidy Barbara S
机构信息
MetroHealthCenter for Skilled Care, Cleveland, Ohio, USA.
出版信息
Geriatr Nurs. 2006 Jan-Feb;27(1):21-3. doi: 10.1016/j.gerinurse.2005.09.012.
Abstract
摘要
相似文献
1
Global "hold-em".全球“梭哈”。
Geriatr Nurs. 2006 Jan-Feb;27(1):21-3. doi: 10.1016/j.gerinurse.2005.09.012.
2
TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.《与贸易有关的知识产权协定》、药品专利与基本药物的获取：从西雅图到多哈的漫长之路
Chic J Int Law. 2002 Spring;3(1):27-46.
3
Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa.向内审视：区域平行贸易作为向非洲提供平价药品的一种手段。
Seton Hall Law Rev. 2011;41(2):625-69.
4
The Health Impact Fund: incentives for improving access to medicines.健康影响基金：改善药品可及性的激励措施。
Lancet. 2010 Jan 9;375(9709):166-9. doi: 10.1016/S0140-6736(09)61296-4.
5
Privatized Pharmaceutical Innovation vs Access to Essential Medicines: A Global Framework for Equitable Sharing of Benefits.私营制药创新与基本药物可及性：公平分享利益的全球框架
JAMA. 2017 Feb 7;317(5):473-474. doi: 10.1001/jama.2016.17994.
6
Questions raised about whether compulsory licenses get best prices.关于强制许可是否能获得最优价格的问题被提了出来。
Nat Med. 2015 Apr;21(4):300. doi: 10.1038/nm0415-300.
7
Drug shortage crisis affects patients and nurses.药品短缺危机影响患者和护士。
Am J Nurs. 2011 Nov;111(11):14. doi: 10.1097/01.NAJ.0000407289.24878.32.
8
Turning over a new leaf versus shaking the tree.
J Neurosci Nurs. 2004 Oct;36(5):243.
9
Introduction: Pharmaceutical firms and the right to health.引言：制药公司与健康权。
J Law Med Ethics. 2012 Summer;40(2):183-7. doi: 10.1111/j.1748-720X.2012.00656.x.
10
TRIPS, pharmaceuticals, developing countries, and the Doha "solution".《与贸易有关的知识产权协定》、药品、发展中国家与多哈“解决方案”
Chic J Int Law. 2002 Spring;3(1):47-68.
Zotero 插件